News Brief: Federal Rescheduling of Marijuana in 2016?
The Drug Enforcement Agency has been in conversation with the FDA on medical marijuana research and its status as a Schedule 1 drug. A letter from the DEA dated April 4th (and released by the Huffington Post April 5th) addressed recent questions from several of the Democratic Senators cosponsoring The Compassionate Access, Research Expansion and Respect States […]
News Brief: Federal Rescheduling of Marijuana in 2016? Read More »









